Literature DB >> 20624971

Profile of Ronald Levy. Interview by Phillip Downey.

Ronald Levy.   

Abstract

Mesh：

Substances：

Year:  2010        PMID： 20624971      PMCID： PMC2919931          DOI： 10.1073/pnas.1008810107

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  13 in total

1.  THE BIOSYNTHESIS OF DELTA-9 AND DELTA-5-MONOSATURATED FATTY ACIDS BY BACTERIA.

Authors:  A J FULCO; R LEVY; K BLOCH
Journal:  J Biol Chem       Date:  1964-04       Impact factor: 5.157

2.  Lymphoma immunotherapy with CpG oligodeoxynucleotides requires TLR9 either in the host or in the tumor itself.

Authors:  Jiali Li; Wenru Song; Debra K Czerwinski; Bindu Varghese; Satoshi Uematsu; Shizuo Akira; Arthur M Krieg; Ronald Levy
Journal:  J Immunol       Date:  2007-08-15       Impact factor: 5.422

3.  The specific cytotoxic effects of daunomycin conjugated to antitumor antibodies.

Authors:  R Levy; E Hurwitz; R Maron; R Arnon; M Sela
Journal:  Cancer Res       Date:  1975-05       Impact factor: 12.701

4.  Tumor-specific idiotype vaccines in the treatment of patients with B-cell lymphoma--long-term results of a clinical trial.

Authors:  F J Hsu; C B Caspar; D Czerwinski; L W Kwak; T M Liles; A Syrengelas; B Taidi-Laskowski; R Levy
Journal:  Blood       Date:  1997-05-01       Impact factor: 22.113

5.  Preliminary observations on the effect of human leukocyte interferon in non-Hodgkin's lymphoma.

Authors:  T C Merigan; K Sikora; J H Breeden; R Levy; S A Rosenberg
Journal:  N Engl J Med       Date:  1978-12-28       Impact factor: 91.245

6.  Synthesis of nuclear-associated proteins by lymphocytes within minutes after contact with phytohemagglutinin.

Authors:  S A Rosenberg; R Levy
Journal:  J Immunol       Date:  1972-04       Impact factor: 5.422

Review 7.  A role for clonal antigens in cancer diagnosis and therapy.

Authors:  L A Lampson; R Levy
Journal:  J Natl Cancer Inst       Date:  1979-02       Impact factor: 13.506

8.  Treatment of B-cell lymphoma with monoclonal anti-idiotype antibody.

Authors:  R A Miller; D G Maloney; R Warnke; R Levy
Journal:  N Engl J Med       Date:  1982-03-04       Impact factor: 91.245

9.  Phase I clinical trial using escalating single-dose infusion of chimeric anti-CD20 monoclonal antibody (IDEC-C2B8) in patients with recurrent B-cell lymphoma.

Authors:  D G Maloney; T M Liles; D K Czerwinski; C Waldichuk; J Rosenberg; A Grillo-Lopez; R Levy
Journal:  Blood       Date:  1994-10-15       Impact factor: 22.113

10.  The monoclonality of human B-cell lymphomas.

Authors:  R Levy; R Warnke; R F Dorfman; J Haimovich
Journal:  J Exp Med       Date:  1977-04-01       Impact factor: 14.307
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.